HeFi-1
HeFi-1 is a mouse anti-CD30 IgG1 monoclonal antibody. HeFi-1 recognizes the ligand-binding site on CD30. HeFi-1 can inhibit the growth of tumor cells with high expression of CD30. HeFi-1 can induce eosinophil apoptosis. HeFi-1 can be used for researches on cancer or inflammation conditions such as anaplastic large-cell lymphoma (ALCL) and asthma[1][2].
Product Specifications
UNSPSC
12352203
Target
Apoptosis; TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
References & Citations
[1]Zhang M, et al. Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors. Blood. 2006 Jul 15;108 (2) :705-10.|[2]Berro AI, et al. Increased expression and activation of CD30 induce apoptosis in human blood eosinophils. J Immunol. 2004 Aug 1;173 (3) :2174-83.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF8/CD30
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1291367-01 48 Tests
Rat Vascular Endothelial Growth Factor D (VEGFD) ELISA Kit
Sign In for Pricing
View Details orb1291367-02 96 Tests
Rat Vascular Endothelial Growth Factor D (VEGFD) ELISA Kit
Sign In for Pricing
View Details 